sepsis
Streck Quality Controls for DiaSorin's Luminex Sepsis Tests Receive FDA Clearance
The quality controls are designed to verify the performance of the Luminex Verigene Blood Culture Gram-Positive and Gram-Negative tests.
T2 Biosystems, Vanderbilt University Medical Center Partner on Prospective Bacterial Sepsis Dx Study
The medical center will evaluate whether the T2Bacteria Panel improves antibiotic usage and clinical interventions for sepsis patients.
Rapid Pathogen ID/AST Market Begins to Recover Post-COVID as Drug-Resistant Infections Spike
Premium
Although bacterial and fungal drug resistance rates increased during the pandemic, a heavy focus on COVID testing has slowed adoption of novel ID/AST technologies.
Todos Medical Subsidiary Inks US Commercialization Deal for Acumen Diagnostics Sepsis PCR Test
Todos Medical acquired the subsidiary, Provista Diagnostics, in early 2021 from Ascenda Biosciences for $7.5 million in cash and stock.
The company's test uses qPCR to measure the expression of two genes to determine the probability of sepsis.
Jan 17, 2023
Nov 7, 2022
Cepheid Nabs CE Mark for Group B Strep Test
Oct 28, 2022
Oct 20, 2022
Sepsis Testing Startup DeepUll Raises €13M
Nov 4, 2021
T2 Biosystems Q3 Revenues Jump 42 Percent
Sep 9, 2021
May 20, 2021